By triple staining using anti-CD14 (Fig. 4C,D) or CD66b (Fig. 4E,F), we were able to confirm that the increase in TF+ MP in BS patients related at least in part to MP release by cells of the monocytic and/or granulocyte lineage. Here, CD14 is linked to Bloom syndrome.